Skip to Content

AN 795 (Imatinib Mesylate 400 mg)

Pill with imprint AN 795 is Brown, Elliptical / Oval and has been identified as Imatinib Mesylate 400 mg. It is supplied by Amneal Pharmaceuticals LLC.

Imatinib is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AN 795

Imatinib mesylate 400 mg AN 795

Imatinib Mesylate

Imprint
AN 795
Strength
400 mg
Color
Brown
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals LLC
National Drug Code (NDC)
65162-0795

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.